CRK•September 28, 2026 at 12:00 PM UTCEnergy

Comstock Signs Framework Agreement for $1.65B SOCAR Investment

Read source article

What happened

Comstock announced signing of a Framework Agreement with SOCAR formalizing the previously announced $1.65 billion strategic partnership in the Haynesville Shale. The agreement sets a target to execute a definitive purchase and sale agreement by October 31, 2026, with transaction close expected by end of 2026. This marks incremental progress from the earlier letter of intent but does not yet provide binding commitment or detailed terms on how the investment will be structured. In the context of Comstock's current financial position—where first-half 2026 operating cash flow of $442.2 million covered only 53% of $829.5 million capex and revolver borrowings stood at $545 million—a successful closing could materially improve liquidity and reduce balance-sheet pressure. However, until a definitive agreement is signed and closing occurs, the company's near-term cash flow deficit remains the dominant fundamental challenge.

Implication

The framework agreement is a positive signal but not yet a binding transaction, so do not underwrite the capital inflow until definitive documents are signed. If the deal closes as planned, the $1.65 billion could significantly strengthen Comstock's liquidity and reduce reliance on the revolver ahead of its November 2027 maturity. Management's guidance implies 2H26 capex of $720-$820 million, meaning the company will likely need additional financing or the SOCAR proceeds to avoid further revolver draws. Investors should monitor for the definitive agreement by October 31, 2026 and closure by year-end, as any slippage would weaken the balance-sheet relief narrative. Until the transaction closes, the investment case still hinges on gas price recovery and production growth, with the stock remaining a wait rather than a buy.

Thesis delta

The signing of the framework agreement is a modest positive for the thesis, as it increases the probability of a meaningful capital injection that could alleviate near-term liquidity and leverage concerns. However, the agreement is not yet definitive and the core issue of weak free cash flow persists. We maintain our WAIT rating and will re-evaluate if a definitive purchase and sale agreement is executed and the transaction closes.

Confidence

Moderate